Nauka i natura

Creative Biolabs

With the spread of the SARS-CoV-2 virus in China, pneumonia caused by this new coronavirus has caused hundreds of deaths and even affected many countries around the world. However, there are still no drugs that show significant therapeutic effects. Through research on a variety of marketed small-molecule drugs, Creative Biolabs found that nelfinavir has a relatively ideal binding free energy and similarity to the ligand model. Therefore, we believe that nelfinavir may be a potential drug to treat SARS-CoV-2 infection. viracept coronavirus
https://sars-cov-2.creative-biolabs.com/nelfinavir-viracept-as-a-candidate-for-sars-cov-2-antiviral-drug.htm